BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33285302)

  • 1. Hepatokines and metabolism: Deciphering communication from the liver.
    Jensen-Cody SO; Potthoff MJ
    Mol Metab; 2021 Feb; 44():101138. PubMed ID: 33285302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
    Kim TH; Hong DG; Yang YM
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of exercise-induced hepatokines in metabolic disorders.
    Ennequin G; Sirvent P; Whitham M
    Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of hepatokines in metabolic disorders and cardiovascular diseases.
    Jung TW; Yoo HJ; Choi KM
    BBA Clin; 2016 Jun; 5():108-13. PubMed ID: 27051596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatokines: unlocking the multi-organ network in metabolic diseases.
    Iroz A; Couty JP; Postic C
    Diabetologia; 2015 Aug; 58(8):1699-703. PubMed ID: 26032022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between hepatokines and metabolic diseases.
    Liang JQ; Liu C; Zhang WX; Chen SY
    Yi Chuan; 2022 Oct; 44(10):853-866. PubMed ID: 36384723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk.
    Berthou F; Sobolewski C; Abegg D; Fournier M; Maeder C; Dolicka D; Correia de Sousa M; Adibekian A; Foti M
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis.
    Garruti G; Baj J; Cignarelli A; Perrini S; Giorgino F
    Front Endocrinol (Lausanne); 2023; 14():1154561. PubMed ID: 37274345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
    Meex RCR; Watt MJ
    Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes.
    Chen RB; Wang QY; Wang YY; Wang YD; Liu JH; Liao ZZ; Xiao XH
    Front Endocrinol (Lausanne); 2023; 14():1094458. PubMed ID: 36936164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans.
    Peter A; Kovarova M; Staiger H; Machann J; Schick F; Königsrainer A; Königsrainer I; Schleicher E; Fritsche A; Häring HU; Stefan N
    Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E266-E273. PubMed ID: 29138227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines.
    Oh KJ; Lee DS; Kim WK; Han BS; Lee SC; Bae KH
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in metabolism and metabolic disorders.
    Rottiers V; Näär AM
    Nat Rev Mol Cell Biol; 2012 Mar; 13(4):239-50. PubMed ID: 22436747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal control of peripheral nutrient partitioning.
    Manceau R; Majeur D; Alquier T
    Diabetologia; 2020 Apr; 63(4):673-682. PubMed ID: 32030470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RABL2 Is Required for Hepatic Fatty Acid Homeostasis and Its Dysfunction Leads to Steatosis and a Diabetes-Like State.
    Yi Lo JC; O'Connor AE; Andrews ZB; Lo C; Tiganis T; Watt MJ; O'Bryan MK
    Endocrinology; 2016 Dec; 157(12):4732-4743. PubMed ID: 27732084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acids as regulators of hepatic lipid and glucose metabolism.
    Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
    Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.
    Takamura T; Misu H; Ota T; Kaneko S
    Endocr J; 2012; 59(9):745-63. PubMed ID: 22893453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
    Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C
    J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the inter-organ crosstalk mediated by ChREBP.
    Carbinatti T; Régnier M; Parlati L; Benhamed F; Postic C
    Front Endocrinol (Lausanne); 2023; 14():1095440. PubMed ID: 36923222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance.
    Watt MJ; Miotto PM; De Nardo W; Montgomery MK
    Endocr Rev; 2019 Oct; 40(5):1367-1393. PubMed ID: 31098621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.